Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mustafa Diken

Showing results (31-40 of 95) with videos related to

Pageof 10
Sort By:
Cancer Immunology Research|April 30, 2014
mTOR inhibition improves antitumor effects of vaccination with antigen-encoding RNAMustafa Diken, Sebastian Kreiter, Fulvia Vascotto, et al.
Human Vaccines & Immunotherapeutics|July 24, 2013
CIMT 2013: advancing targeted therapies--report on the 11th Annual Meeting of the Association for Cancer Immunotherapy, May 14-16 2013, Mainz, GermanyMustafa Diken, Sebastian Attig, Christian Grunwitz, et al.
Hepatology (Baltimore, Md.)|June 23, 2015
Specific hepatic delivery of procollagen α1(I) small interfering RNA in lipid-like nanoparticles resolves liver fibrosisCarolina Jiménez Calvente, Alfica Sehgal, Yury Popov, et al.
EJNMMI Research|February 11, 2021
Iodine-124 PET quantification of organ-specific delivery and expression of NIS-encoding RNAMatthias Miederer, Stefanie Pektor, Isabelle Miederer, et al.
Chemical Society Reviews|November 23, 2018
Nanomedicine and macroscale materials in immuno-oncologyQingxue Sun, Matthias Barz, Bruno G De Geest, et al.
Human Vaccines & Immunotherapeutics|October 5, 2019
CIMT 2019: report on the 17th Annual Meeting of the Association for Cancer ImmunotherapyJan David Beck, Matthias Birtel, Erik Haefner, et al.
Journal of Translational Medicine|November 28, 2021
CRISPR/Cas9-mediated TGFβRII disruption enhances anti-tumor efficacy of human chimeric antigen receptor T cells in vitroKhadijeh Alishah, Matthias Birtel, Elham Masoumi, et al.
Cancer Research|August 6, 2011
FLT3 ligand enhances the cancer therapeutic potency of naked RNA vaccinesSebastian Kreiter, Mustafa Diken, Abderraouf Selmi, et al.
Nature Communications|November 17, 2017
FBXO32 promotes microenvironment underlying epithelial-mesenchymal transition via CtBP1 during tumour metastasis and brain developmentSanjeeb Kumar Sahu, Neha Tiwari, Abhijeet Pataskar, et al.
International Journal of Radiation Oncology, Biology, Physics|January 1, 2024
Carbon Ion and Photon Radiation Therapy Show Enhanced Antitumoral Therapeutic Efficacy With Neoantigen RNA-LPX Vaccines in Preclinical Colon Carcinoma ModelsNadja Salomon, Alexander Helm, Abderaouf Selmi, et al.
Pageof 10

Showing results (31-40 of 95) with videos related to

Sort By:
Pageof 10
Cancer Immunology Research|April 30, 2014
mTOR inhibition improves antitumor effects of vaccination with antigen-encoding RNAMustafa Diken, Sebastian Kreiter, Fulvia Vascotto, et al.
Human Vaccines & Immunotherapeutics|July 24, 2013
CIMT 2013: advancing targeted therapies--report on the 11th Annual Meeting of the Association for Cancer Immunotherapy, May 14-16 2013, Mainz, GermanyMustafa Diken, Sebastian Attig, Christian Grunwitz, et al.
Hepatology (Baltimore, Md.)|June 23, 2015
Specific hepatic delivery of procollagen α1(I) small interfering RNA in lipid-like nanoparticles resolves liver fibrosisCarolina Jiménez Calvente, Alfica Sehgal, Yury Popov, et al.
EJNMMI Research|February 11, 2021
Iodine-124 PET quantification of organ-specific delivery and expression of NIS-encoding RNAMatthias Miederer, Stefanie Pektor, Isabelle Miederer, et al.
Chemical Society Reviews|November 23, 2018
Nanomedicine and macroscale materials in immuno-oncologyQingxue Sun, Matthias Barz, Bruno G De Geest, et al.
Human Vaccines & Immunotherapeutics|October 5, 2019
CIMT 2019: report on the 17th Annual Meeting of the Association for Cancer ImmunotherapyJan David Beck, Matthias Birtel, Erik Haefner, et al.
Journal of Translational Medicine|November 28, 2021
CRISPR/Cas9-mediated TGFβRII disruption enhances anti-tumor efficacy of human chimeric antigen receptor T cells in vitroKhadijeh Alishah, Matthias Birtel, Elham Masoumi, et al.
Cancer Research|August 6, 2011
FLT3 ligand enhances the cancer therapeutic potency of naked RNA vaccinesSebastian Kreiter, Mustafa Diken, Abderraouf Selmi, et al.
Nature Communications|November 17, 2017
FBXO32 promotes microenvironment underlying epithelial-mesenchymal transition via CtBP1 during tumour metastasis and brain developmentSanjeeb Kumar Sahu, Neha Tiwari, Abhijeet Pataskar, et al.
International Journal of Radiation Oncology, Biology, Physics|January 1, 2024
Carbon Ion and Photon Radiation Therapy Show Enhanced Antitumoral Therapeutic Efficacy With Neoantigen RNA-LPX Vaccines in Preclinical Colon Carcinoma ModelsNadja Salomon, Alexander Helm, Abderaouf Selmi, et al.
Pageof 10